Saturday 17 October 2026
Export RVTY’s income statement to Excel — free account
Revvity Inc.
RVTY Healthcare Diagnostics & Research
Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
152.64
2.07
−1.34%
Follow RVTY
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
3.10% | 3.23% | 3.23% | 3.21% | |
Piotroski F-Score |
6 | 6 | 6 | 6 | |
| 1.91% | 1.96% | 1.97% | 1.95% | ||
ROIC |
2.35% | 2.33% | 2.36% | 2.38% | |
Return on Tangible Assets |
16.75% | 17.38% | 17.68% | 16.08% | |
Average Days of Receivables |
88.26 | 95.17 | 86.95 | 88.90 | |
Free Cash Flow per Share |
4.31 | 4.37 | 4.49 | 5.11 | |
Free Cash Flow |
497.40 | 509.41 | 501.70 | 570.15 | |
Capital Expenditures |
(77.80) | (73.52) | (68.31) | (57.48) | |
| Other line items | |||||
Cash ROIC |
4.32% | 4.47% | 4.46% | 4.98% | |
Accounts Receivable Turnover |
4.39 | 4.15 | 4.44 | 4.25 | |
Accounts Payable Turnover |
7.15 | 7.32 | 7.63 | 7.62 | |
Inventory Turnover |
3.21 | 3.46 | 3.45 | 3.42 | |
Average Days of Payables |
50.99 | 52.41 | 46.71 | 46.14 | |
Days of Inventory on Hand |
110.20 | 107.24 | 106.67 | 105.38 | |
Tax Rate |
(0.14) | (0.11) | (0.10) | (0.09) | |
Research and Development Expense of Revenue |
7.35% | 7.56% | 7.58% | 7.41% | |
Selling, General and Administrative Expense of Revenue |
34.99% | 34.73% | 34.32% | 35.24% | |
Share Based Compensation of Revenue |
1.14% | 0.80% | 0.82% | 0.84% | |
Interest Coverage |
3.94 | 4.04 | 3.82 | 3.66 | |
Operating CF/Net income |
2.42 | 2.42 | 2.38 | 2.64 | |
Depreciation/Fixed assets |
0.83 | 0.86 | 0.90 | 0.91 | |
Capex/Depreciation |
(0.19) | (0.18) | (0.16) | (0.14) | |
Revenue per Share |
24.38 | 24.51 | 25.95 | 26.10 | |
Operating CF per Share |
4.98 | 5.00 | 5.10 | 5.62 | |
Capex per Share |
(0.67) | (0.63) | (0.61) | (0.52) | |
Capex to Sales |
0.03 | 0.03 | 0.02 | 0.02 |
Columns are period end dates